Your browser doesn't support javascript.
loading
Treatment pathways and associated costs of metastatic colorectal cancer in Greece.
Sougklakos, Ioannis; Athanasiadis, Elias; Boukovinas, Ioannis; Karamouzis, Michalis; Koutras, Aggelos; Papakotoulas, Paulos; Latsou, Dimitra; Hatzikou, Magda; Stamuli, Eugena; Balasopoulos, Athanasios; Sideris, Aggelos.
Affiliation
  • Sougklakos I; Laboratory of Translation Oncology, University Hospital of Crete Medical School, Crete, Greece.
  • Athanasiadis E; Ygeia Athens Hospital, Marousi, Greece.
  • Boukovinas I; Bioclinic Oncology Department Thessaloniki, Thessaloniki, Greece.
  • Karamouzis M; Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Koutras A; University of Patras, Patras, Greece.
  • Papakotoulas P; Theagenion Anticancer Hospital, Thessaloniki, Greece.
  • Latsou D; Pharmecons Easy Access, Athens, Greece.
  • Hatzikou M; Pharmecons Easy Access, Athens, Greece. magda.chatzikou@pharmecons.com.
  • Stamuli E; Pharmecons Easy Access, Athens, Greece.
  • Balasopoulos A; Pierre Fabre Farmaka S.A., Agia Paraskevi, Greece.
  • Sideris A; Pierre Fabre Farmaka S.A., Agia Paraskevi, Greece.
Cost Eff Resour Alloc ; 20(1): 7, 2022 Feb 14.
Article in En | MEDLINE | ID: mdl-35164784

Full text: 1 Database: MEDLINE Type of study: Health_economic_evaluation / Risk_factors_studies Language: En Journal: Cost Eff Resour Alloc Year: 2022 Type: Article Affiliation country: Greece

Full text: 1 Database: MEDLINE Type of study: Health_economic_evaluation / Risk_factors_studies Language: En Journal: Cost Eff Resour Alloc Year: 2022 Type: Article Affiliation country: Greece